Genesystem Co., Ltd.

Genesystem Co., Ltd. is a South Korean biotech engineering company specializing in point-of-care molecular diagnostic solutions. The company develops rapid PCR-based testing platforms utilizing proprietary biochip and ultra-fast PCR technologies for on-site molecular diagnostics. Primary product lines include the UF-series instruments (UF-300, UF-340, UF-100, UF-150) designed for rapid DNA amplification and qPCR applications, complemented by consumables including Rapi:chip cartridges, PCR reagents optimized for ultra-fast performance, and nucleic acid extraction kits. Assay portfolio spans human pathogen detection (SARS-CoV-2, influenza, RSV, tuberculosis, HPV, STIs), veterinary diagnostics (canine and feline disease panels for skin, respiratory, gastrointestinal, and neurological conditions; livestock diagnostics for ASFV, SBV, FMDV), and food safety applications (foodborne pathogen detection, halal assurance, meat authentication). The company emphasizes multiplex capability, rapid sample-to-result turnaround (20-minute DNA amplification), and miniaturized heating module technology. Genesystem exhibits internationally at major diagnostic conferences (MEDICA, AACC, IFCC) and maintains a global network of distributors. Manufacturing and R&D focus on biochip-based multiplex POCT solutions with expansion into biomarker development and diversified multiplex diagnostic applications.